Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ulmer

Showing results (51-60 of 174) with videos related to

Pageof 18
Sort By:
Frontiers in Immunology|August 6, 2013
Vaccine adjuvants: mode of actionEnnio De Gregorio, Elena Caproni, Jeffrey B Ulmer
Human Vaccines|October 14, 2006
Role of neutralizing antibodies in protective immunity against HIVIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Developments in Biological Standardization|December 17, 1998
DNA vaccinesJ J Donnelly, J B Ulmer, M A Liu
Seminars in Immunology|June 6, 2013
RNA: the new revolution in nucleic acid vaccinesAndrew J Geall, Christian W Mandl, Jeffrey B Ulmer
European Journal of Immunology|July 1, 1994
Presentation of an exogenous antigen by major histocompatibility complex class I moleculesJ B Ulmer, J J Donnelly, M A Liu
Biochemical and Biophysical Research Communications|September 16, 1992
Common peptide epitopes in glycophorin and the endothelial sialoglycoprotein gp60J E Schnitzer, J B Ulmer, G E Palade
Cellular Microbiology|October 9, 2003
Innate immunity and biodefence vaccinesNicholas M Valiante, Derek T O'Hagan, Jeffrey B Ulmer
Annals of the New York Academy of Sciences|November 27, 1995
Protective efficacy of intramuscular immunization with naked DNAJ J Donnelly, J B Ulmer, M A Liu
Expert Review of Vaccines|August 3, 2004
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine designIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
A major endothelial plasmalemmal sialoglycoprotein, gp60, is immunologically related to glycophorinJ E Schnitzer, J B Ulmer, G E Palade
Pageof 18

Showing results (51-60 of 174) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|August 6, 2013
Vaccine adjuvants: mode of actionEnnio De Gregorio, Elena Caproni, Jeffrey B Ulmer
Human Vaccines|October 14, 2006
Role of neutralizing antibodies in protective immunity against HIVIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Developments in Biological Standardization|December 17, 1998
DNA vaccinesJ J Donnelly, J B Ulmer, M A Liu
Seminars in Immunology|June 6, 2013
RNA: the new revolution in nucleic acid vaccinesAndrew J Geall, Christian W Mandl, Jeffrey B Ulmer
European Journal of Immunology|July 1, 1994
Presentation of an exogenous antigen by major histocompatibility complex class I moleculesJ B Ulmer, J J Donnelly, M A Liu
Biochemical and Biophysical Research Communications|September 16, 1992
Common peptide epitopes in glycophorin and the endothelial sialoglycoprotein gp60J E Schnitzer, J B Ulmer, G E Palade
Cellular Microbiology|October 9, 2003
Innate immunity and biodefence vaccinesNicholas M Valiante, Derek T O'Hagan, Jeffrey B Ulmer
Annals of the New York Academy of Sciences|November 27, 1995
Protective efficacy of intramuscular immunization with naked DNAJ J Donnelly, J B Ulmer, M A Liu
Expert Review of Vaccines|August 3, 2004
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine designIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
A major endothelial plasmalemmal sialoglycoprotein, gp60, is immunologically related to glycophorinJ E Schnitzer, J B Ulmer, G E Palade
Pageof 18